Supply Chain Intelligence

Corcept Therapeutics Incorporated Supply Chain

CORT supply chain intelligence for Corcept Therapeutics Incorporated: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

CORT ·Last updated 2026-09-14 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
13Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Corcept Therapeutics Incorporated (CORT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

22Total relationships
2Distinct source URLs
7High confidence
0.741Average confidence
2026-09-14Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Corcept Therapeutics Incorporated Suppliers

TickerNameConfidenceEvidence
OPTIME-CARE-INC OPTIME-CARE-INC 90% the specialty pharmacy that previously served as our exclusive specialty pharmacy services vendor dispensing Korlym and the authorized generic version of Korlym and performing related pharmacy and pa…
BRK-B Berkshire Hathaway Inc. 80% Reciprocal relationship from BRK-B graph: Reciprocal relationship from CORT graph: Reciprocal relationship from BRK-B graph: Our other service businesses franchise and service a network of quick serv…
ORANY ORANY 72% mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to re…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CORT graph: mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities i…
XERS Xeris Biopharma Holdings, Inc. 72% ol synthesis inhibitor osilodrostat to treat patients with Cushing’s disease, which approval was broadened in April 2025 to include adult patients with any etiology of hypercortisolism. 24 In 2021, X…
XERS Xeris Biopharma Holdings, Inc. 72% Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device…

Corcept Therapeutics Incorporated Customers

TickerNameConfidenceEvidence
OPTIME-CARE-INC OPTIME-CARE-INC 85% Antitrust Litigation On June 13, 2024, Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al. (N.D. Cal.), Case …
TEVA-PHARMACEUTICALS-USA-INC TEVA-PHARMACEUTICALS-USA-INC 80% Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al.
ORANY ORANY 72% mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to re…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from CORT graph: mentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities i…
XERS Xeris Biopharma Holdings, Inc. 72% range of disorders, including central serous retinopathy, post-traumatic stress disorder, anxiety, alcoholism, cocaine addiction, Alzheimer’s disease, ALS, hypercortisolism, metabolic syndrome, ather…
XERS Xeris Biopharma Holdings, Inc. 72% Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device…
HEALTH-CARE-SERVICE-CORPORATION HEALTH-CARE-SERVICE-CORPORATION 70% several named plaintiffs filed a complaint against Corcept in the Alameda County Superior Court for the State of California, captioned, Aetna Inc., Health Care Service Corporation, Humana Inc. and Mo…
MOLINA-HEALTHCARE-INC MOLINA-HEALTHCARE-INC 70% several named plaintiffs filed a complaint against Corcept in the Alameda County Superior Court for the State of California, captioned, Aetna Inc., Health Care Service Corporation, Humana Inc. and Mo…
AETNA-INC-HEALTH-CARE-SERVICE-CORPORATION-HUMANA AETNA-INC-HEALTH-CARE-SERVICE-CORPORATION-HUMANA 62% Antitrust Litigation On June 13, 2024, Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al. (N.D. Cal.), Case …
CAPITAL-RESOURCES CAPITAL-RESOURCES 62% this provision will limit the revenue we receive from Medicare patients and may materially reduce our profits in 2026 and beyond. The IRA permits CMS to negotiate prices for certain high-expenditure …
CORCEPT-THERAPEUTICS-INC CORCEPT-THERAPEUTICS-INC 62% Antitrust Litigation On June 13, 2024, Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al. (N.D. Cal.), Case …
HIKMA-PHARMACEUTICALS-USA-INC HIKMA-PHARMACEUTICALS-USA-INC 62% nge on appeal. Risks Related to our Stock • The price of our common stock fluctuates widely and is likely to continue to do so. Opportunities for investors to sell shares may be limited. • Our stock …
SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED 62% nge on appeal. Risks Related to our Stock • The price of our common stock fluctuates widely and is likely to continue to do so. Opportunities for investors to sell shares may be limited. • Our stock …

Corcept Therapeutics Incorporated Debt Obligations

InstrumentDescriptionConfidenceEvidence
CORT-DEBT Debt stack $9.6M 90% Market cache reports total debt of $9.6M.
CORT-DEBT-8797 Xbrl Convertible 90% xbrl convertible detail from xbrl 2011-12-31.

Corcept Therapeutics Incorporated Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Corcept Therapeutics Incorporated.

Corcept Therapeutics Incorporated Ownership

HolderNameConfidenceEvidence
CORT-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 357 tracked holders.

Corcept Therapeutics Incorporated Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BRK-B Berkshire Hathaway Inc. 100.00 1 ['supplier']
ORANY ORANGE 100.00 1 ['customer', 'supplier']
BRIA BrilliA Inc 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
OXY Occidental Petroleum Corporation 50.00 2
D Dominion Energy, Inc. 50.00 2
EQR Equity Residential 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
HIG The Hartford Insurance Group, Inc. 50.00 2
CANF Can-Fite BioPharma Ltd. 50.00 2
DFTX Definium Therapeutics, Inc. 50.00 2
CHUC Charlie's Holdings, Inc. 50.00 2
CLNE Clean Energy Fuels Corp. 50.00 2
FENC Fennec Pharmaceuticals Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
CNOB ConnectOne Bancorp, Inc. 50.00 2
DWTX Dogwood Therapeutics, Inc. 50.00 2
ESS Essex Property Trust, Inc. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
Browse supply chain intel →

See the full supply chain map, all relationships, and real-time alerts for Corcept Therapeutics Incorporated.

Unlock full CORT data — View plans →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map
🔐
CORT
Unlock CORT Supply Chain Data
Verified relationships include:
OPTIME-CARE-INCOPTIME-CARE-INCSupplier90%
BRK-BBerkshire Hathaway Inc.Supplier80%
OPTIME-CARE-INCOPTIME-CARE-INCCustomer85%
TEVA-PHARMACEUTICALS-USA-INCTEVA-PHARMACEUTICALS-USA-INCCustomer80%
+18 more relationships locked
Subscribe — View plans →
Already a subscriber? Sign in →